ISOMETHEPTENE‐A NON‐ERGOT DRUG IN THE TREATMENT OF MIGRAINE

@article{Diamond1975ISOMETHEPTENEAND,
  title={ISOMETHEPTENE‐A NON‐ERGOT DRUG IN THE TREATMENT OF MIGRAINE},
  author={Sharon Diamond and Jos{\'e} Lu{\'i}s Medina},
  journal={Headache: The Journal of Head and Face Pain},
  year={1975},
  volume={15}
}
  • S. Diamond, J. Medina
  • Published 1 October 1975
  • Geology, Medicine
  • Headache: The Journal of Head and Face Pain
SYNOPSIS 
Comparative Study of a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen and Sumatriptan Succinate in the Treatment of Migraine
Objective.—To compare the safety and efficacy of isometheptene mucate, dichloralphenazone with acetaminophen to sumatriptan succinate for the treatment of mild‐to‐moderate migraine, with or without
The pharmacological management of migraine, part 1: overview and abortive therapy.
  • G. Demaagd
  • Medicine, Psychology
    P & T : a peer-reviewed journal for formulary management
  • 2008
TLDR
Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.
Pharmacological Management of Migraine
TLDR
This chapter will cover typical medications used and the development of pharmacological plans for use during the acute migraine attack and longer term migraine management, as well as briefly covering Emergency Department management and inpatient management of migraine.
Fixed Drug Combinations for the Acute Treatment of Migraine
  • E. Loder
  • Medicine, Psychology
    CNS drugs
  • 2005
TLDR
With renewed interest in the use of FDCs for the acute treatment of migraine, high-quality evidence of a benefit for such treatments is emerging, and the most consistent and impressive evidence of benefit is for NSAID-containing F DCs.
Practical Approaches to Migraine Management
TLDR
Preventative medication therapy is indicated for patients experiencing frequent and/or refractory attacks and recently published evidence-based guidelines advocate migraine-specific drugs, such as serotonin 5-HT1b/1d agonists and dihydroergotamine mesylate, for patients experience moderate to severe migraine attacks.
The severity model of chronic headache
TLDR
Primary care physicians have abundant opportunities to amplify research on the psychosomatic sources of headache, develop and refine the utility of the severity model, and elucidate the role of the physician — patient relationship as a specific form of treatment.
...
...

References

SHOWING 1-7 OF 7 REFERENCES
CONTROLLED STUDIES OF A NEW AGENT IN VASCULAR HEADACHE
  • H. Ogden
  • Medicine, Psychology
    Headache
  • 1963
TLDR
It is shown that pain in the frontal area is the most common type involved in chronic vascular headaches, and the syndrome is named "Frontal Headache.
Recent advances in treatment of migraine.
TLDR
Treatment of migraine has posed a problem for many years and the number and multiplicity of therapeutic agents and the uniformly good results reported with these medicaments indicate the unsatisfactory state of knowledge concerning treatment.
Practical drug treatment of migraine headache.
  • J. Oatman
  • Psychology
    Antibiotic medicine & clinical therapy
  • 1956
Headache Clinics IV: The Use of Octin in the Treatment of Headache
  • Am. Pract. 4:31-34,
  • 1953
Studies in the Pharmacology of Headache
  • Neurology
  • 1963
Ad Hoc Committee on Classification of Headache, National Institute of Neurological Diseases and Blindness, National institute of Health
  • JAMA
  • 1962
eds).: The Pharmacological Basis of Therapeutics, ed
  • 1970